.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
UBS
Julphar
Cerilliant
Moodys
Colorcon
QuintilesIMS
Cantor Fitzgerald
Healthtrust
Queensland Health

Generated: September 22, 2017

DrugPatentWatch Database Preview

CETIRIZINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Cetirizine Hydrochloride, and when can generic versions of Cetirizine Hydrochloride launch?

Cetirizine Hydrochloride is a drug marketed by Taro, Apotex Inc, Actavis Mid Atlantic, Aurobindo Pharma Ltd, Wockhardt, Amneal Pharms, Bio Pharm Inc, Ranbaxy Labs Ltd, Silarx, Teva Pharms, Breckenridge Pharm, Allied Pharma Inc, Vintage, Perrigo R And D, Actavis Elizabeth, Cipla Ltd, Bionpharma Inc, Unique Pharm Labs, Sun Pharm Inds Inc, Jubilant Cadista, Dr Reddys Labs Ltd, Sandoz, Contract Pharmacal, Orchid Hlthcare, Ipca Labs Ltd, Mylan, Amneal Pharms Ny, Unichem, Strides Pharma, Torrent Pharms Llc, Sun Pharm Inds Ltd, and Ivax Sub Teva Pharms. and is included in forty-two NDAs.

The generic ingredient in CETIRIZINE HYDROCHLORIDE is cetirizine hydrochloride; pseudoephedrine hydrochloride. There are thirty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the cetirizine hydrochloride; pseudoephedrine hydrochloride profile page.

Summary for Tradename: CETIRIZINE HYDROCHLORIDE

Patents:0
Applicants:32
NDAs:42
Suppliers / Packagers: see list15
Bulk Api Vendors: see list147
Clinical Trials: see list2,322
Patent Applications: see list3,572
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CETIRIZINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: CETIRIZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
CETIRIZINE HYDROCHLORIDE HIVES
cetirizine hydrochloride
TABLET;ORAL078343-002Jan 15, 2008OTCNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
TABLET;ORAL090760-003Aug 5, 2015OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo R And D
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
TABLET;ORAL078336-001Dec 27, 2007OTCNoNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
cetirizine hydrochloride
CAPSULE;ORAL022429-002Jul 23, 2009OTCYesYes► Subscribe► Subscribe► Subscribe
Mylan
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
TABLET;ORAL076677-002Dec 27, 2007OTCNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
TABLET;ORAL077499-001Dec 27, 2007OTCNoNo► Subscribe► Subscribe► Subscribe
Taro
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
TABLET;ORAL078072-003Jul 22, 2009OTCNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Ny
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
TABLET;ORAL078780-001Jan 21, 2010OTCNoNo► Subscribe► Subscribe► Subscribe
Strides Pharma
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
CAPSULE;ORAL205291-001Jul 21, 2017OTCNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms Llc
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
cetirizine hydrochloride
TABLET;ORAL079191-003Apr 15, 2010OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Citi
Deloitte
McKinsey
US Department of Justice
Healthtrust
Argus Health
AstraZeneca
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot